NOME and AstraZeneca’s BioVentureHub are proud to announce a strategic partnership dedicated to enhancing innovation within the Nordic life science ecosystem. This collaboration aims to provide unparalleled support and opportunities for promising startups and founders, ensuring they thrive in an environment tailored to their needs.
By combining our extensive expertise and mentorship capabilities, we are committed to offering personalised assistance to companies and individuals, perfectly aligned with their specific requirements. Startups participating in either of our programmes now have easier access to the resources and support of the other organisation, enhancing their potential for success.
“I am thrilled about our new partnership with AstraZeneca BioVentureHub. The BioVentureHub represents an organization of excellence within the innovation ecosystem, with deep insights into technology and commercialization and a portfolio of very high-quality startups. At NOME, we warmly welcome the BioVentureHub as a new partner and as a valuable link to a corporate pharma organization.” – Peter Birk
“The AstraZeneca BioVentureHub is thrilled to partner with NOME, offering our member companies access to a diverse, high-quality mentor network to support their growth journey. We are also excited to provide NOME companies the opportunity to access the BioVentureHub environment, connect with NOME and other network partners, and to share and learn from their extensive experience in mentoring companies across the entire Life Science spectrum” – Robert Roth, Science Director, AstraZeneca BioVentureHub.
The complementary nature of our programmes allows us to deliver precise and impactful support to life science companies in the Nordics. Whether through the advanced technological and commercialisation insights of BioVentureHub or the experienced mentorship of NOME, our partnership significantly increases the chances of success for participating companies.
